Raha Abdul Rahim Selected Research

nordamnacanthal

6/2022	Ultrastructural and Morphological Effects in T-Lymphoblastic Leukemia CEM-SS Cells Following Treatment with Nordamnacanthal and Damnacanthal from Roots of Morinda elliptica.
3/2021	Anticancer Potential of Damnacanthal and Nordamnacanthal from Morinda elliptica Roots on T-lymphoblastic Leukemia Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raha Abdul Rahim Research Topics

Disease

5	Neoplasms (Cancer) 06/2022 - 09/2017
3	Infections 03/2022 - 01/2017
3	Wounds and Injuries (Trauma) 01/2018 - 09/2017
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022 - 03/2021
2	Human Influenza (Influenza) 01/2017 - 01/2017
1	Necrosis 06/2022
1	Myalgia 07/2019
1	Leukemia 06/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 10/2017

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 06/2022 - 09/2017
2	damnacanthalIBA 06/2022 - 03/2021
2	nordamnacanthalIBA 06/2022 - 03/2021
2	Amino Acids FDA Link 07/2019 - 01/2018
2	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 01/2017
1	AnthraquinonesIBA 06/2022
1	AntioxidantsIBA 06/2022
1	ChromatinIBA 06/2022
1	EnzymesIBA 03/2022
1	endolysinIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Trypan Blue FDA Link 06/2019
1	Bromodeoxyuridine (BrdU)IBA 06/2019
1	VaccinesIBA 01/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018
1	Codon (Codons)IBA 01/2018
1	SilverIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Protein Subunit VaccinesIBA 01/2018
1	Zinc Oxide FDA Link 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 09/2017
1	Single-Chain AntibodiesIBA 01/2017
1	Recombinant ProteinsIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 01/2017

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2018 - 01/2018